𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical impact of K-rasmutation in colorectal cancer patients treated with adjuvant FOLFOX

✍ Scribed by Myung Hee Chang; In Kyu Lee; Yoon Si; Kyu Sang Lee; In-Sook Woo; Jae Ho Byun

Book ID
105993611
Publisher
Springer
Year
2010
Tongue
English
Weight
330 KB
Volume
68
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of adjuvant mitotane on the clini
Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer
✍ Rena Vassilopoulou-Sellin; Mary J. Klein; Pamela N. Schultz; Naguib A. Samaan; V πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 456 KB πŸ‘ 2 views

Background. Adrenocortical carcinoma is a rare and aggressive disease with a poor prognosis. Adjuvant mitotane administration has been suggested as a strategy that might improve the outcome of patients with localized disease. Methods. The authors analyzed the clinical out- come of patients with loc

Clinical outcome of colorectal cancer pa
Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody
✍ Gavin W. L. Denton; Lindy G. Durrant; Jack D. Hardcastle; Eric B. Austin; Herb F πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 600 KB

## Abstract A human monoclonal anti‐idiotypic antibody (105AD7) has been developed which mimics a colorectal‐tumour‐associated antigen and induces cellular anti‐colorectal tumour immune responses in animals. Thirteen patients with advanced colorectal cancer were immunized with 105AD7 and their surv